Back
Grifols SA Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
55
GRFS
Grifols SA
Last Price:
8.75
Seasonality Move:
0.19%
Sell
23
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.03
Seasonality Move:
-31.44%
Buy
55
Grifols SA (GRFS)
is a Buy
Is Grifols SA a Buy, Sell or Hold?
- The current Grifols SA [GRFS] share price is $8.90. The Score for GRFS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GRFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.05. The Score for ADAP is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRFS Stock Price Chart
What is Grifols SA's stock price today?
-
The Grifols SA share price today is $8.90
The current trend is moderately bullish and GRFS is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
GRFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 56.06 | Buy |
| Chaikin Money Flow: | -643937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.56 - 9.3) | Buy |
| Bollinger Bands (100): | (6.75 - 8.41) | Buy |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.65 | Sell |
| Chaikin Money Flow: | -574860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.06 - 1.22) | Sell |
| Bollinger Bands (100): | (1 - 1.22) | Sell |
GRFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.9 | Buy |
| 20-day SMA: | 8.79 | Buy |
| 50-day SMA: | 8.13 | Buy |
| 200-day SMA: | 7.86 | Buy |
| 8-day EMA: | 9 | Sell |
| 20-day EMA: | 8.71 | Buy |
| 50-day EMA: | 8.19 | Buy |
| 200-day EMA: | 7.93 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.17 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.12 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.1 | Sell |
Grifols SA Earnings Growth & GRFS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.29 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Grifols SA Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||